{"id":"W4313201977","doi":"10.1016/j.ejim.2022.12.008","title":"De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?","year":2022,"lang":"en","type":"review","venue":"European Journal of Internal Medicine","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; Sanofi; Esperion Therapeutics; MicroPort; Teva Pharmaceutical Industries; Daiichi Sankyo Europe; Eli Lilly and Company; Servier; Amgen","keywords":"Prasugrel; Medicine; Ticagrelor; Clopidogrel; Antithrombotic; Percutaneous coronary intervention; Acute coronary syndrome; P2Y12; Aspirin; Conventional PCI; Cardiology; Cangrelor; Internal medicine; Coronary artery disease; Intensive care medicine; Myocardial infarction","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001296426,0.0003935496,0.001926663,0.0005473426,0.00002812842,0.00001073011,0.0003546749,0.00004138491,0.001037594],"category_scores_gemma":[0.00009832517,0.0002437066,0.0005946342,0.0003566268,0.00005752699,0.0001157673,0.00005558818,0.0006710889,0.0000310313],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001501214,"about_ca_system_score_gemma":0.0002136786,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002213705,"about_ca_topic_score_gemma":1.005384e-7,"domain_scores_codex":[0.9964249,0.00095539,0.001200077,0.000250133,0.0009150044,0.000254482],"domain_scores_gemma":[0.9980657,0.00006840235,0.0009285184,0.0003253439,0.0001821332,0.0004299576],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005015959,0.0003984265,0.004343083,0.001239293,0.001441791,0.008171442,0.0001584368,0.000007575651,0.0000015616,6.282691e-7,0.001078405,0.9781434],"study_design_scores_gemma":[0.009755578,0.01373427,0.1755424,0.05524643,0.001718878,0.002119851,0.00009656336,0.000003568727,6.067354e-7,0.000001985165,0.7414361,0.0003437683],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.04120966,0.9569731,0.00006101625,0.0001318245,0.0002163305,0.0008673946,0.00004119656,0.00001161774,0.0004878934],"genre_scores_gemma":[0.0372077,0.9609136,0.00003611628,0.0005114292,0.000924595,0.000008302233,0.00009112036,0.0001173953,0.0001897618],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9777997,"threshold_uncertainty_score":0.9998756,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04083980696039211,"score_gpt":0.2902026497031686,"score_spread":0.2493628427427765,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}